Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MD › Bethesda › NPI 1205896446
Hospital

Suburban Hospital, INC.

Suburban Hospital, INC. was paid $3.28M by Medicaid between Jan 2018 and Dec 2024, across 75 billing codes. Its largest line is 99284, emergency room visit (serious) — 39% of everything it billed.

33Billing provider infoSUBURBAN HOSPITAL, INC.
BETHESDA, MD 20814
33aNPI1205896446assigned 03/23/2006
33bProvider typePsychiatric Hospital
28Total paid$3.28M
24GClaims104,616
24DCodes billed75
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201820,323$746K
201918,544$482K
20209,827$401K
202114,678$506K
202217,403$555K
202314,402$333K
2024incomplete9,439$253K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 39% 5,245 4,660 $1.26M
G0378 Hospital observation service, per hour 21% 1,156 942 $698K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 4,308 3,719 $624K
99281 Emergency department visit for the evaluation and management, self-limited or minor 4.0% 2,182 1,732 $131K
80053 Comprehensive metabolic panel 3.2% 9,295 7,086 $104K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.4% 846 706 $79K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.3% 187 172 $75K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.4% 9,454 7,720 $47K
70450 Computed tomography, head or brain; without contrast material <1% 1,969 1,699 $29K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,532 1,398 $24K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 475 424 $23K
71045 Radiologic examination, chest; single view <1% 2,696 2,399 $21K
63 more codes
84484 <1% 4,684 $21K
80048 Basic metabolic panel (calcium, ionized) <1% 2,027 $13K
72125 Computed tomography, cervical spine; without contrast material <1% 457 $12K
J3490 Unclassified drugs <1% 1,211 $10K
81001 <1% 3,391 $9K
87040 <1% 564 $8K
85610 <1% 4,541 $7K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 216 $7K
83690 <1% 2,898 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 681 $5K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,364 $5K
83735 <1% 3,743 $5K
87631 <1% 169 $4K
A9270 Non-covered item or service <1% 13,870 $4K
85730 <1% 2,577 $4K
82962 <1% 2,565 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 408 $4K
J2704 Injection, propofol, 10 mg <1% 1,399 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 431 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,898 $2K
84703 <1% 188 $2K
85027 <1% 1,295 $2K
82077 <1% 140 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 642 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,210 $2K
86850 <1% 83 $2K
36415 Collection of venous blood by venipuncture <1% 1,428 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 705 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 490 $1K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 164 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,252 $922.16
83605 <1% 791 $919.85
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 676 $801.73
71046 Radiologic examination, chest; 2 views <1% 62 $784.58
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 340 $733.90
83880 <1% 209 $604.65
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 63 $554.75
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 762 $517.76
J1644 Injection, heparin sodium, per 1000 units <1% 64 $457.02
J2270 Injection, morphine sulfate, up to 10 mg <1% 142 $381.48
90715 <1% 26 $303.88
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 31 $303.32
83036 Hemoglobin; glycosylated (A1C) <1% 56 $249.66
J1650 Injection, enoxaparin sodium, 10 mg <1% 84 $156.02
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 50 $143.10
C1769 Guide wire <1% 31 $130.62
82150 <1% 28 $74.88
86901 <1% 42 $61.45
86900 <1% 42 $61.45
J1815 Injection, insulin, per 5 units <1% 19 $42.79
80061 Lipid panel <1% 13 $35.03
84132 <1% 384 $22.31
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 0% 127 $0.00
82435 0% 206 $0.00
97162 0% 29 $0.00
84443 Thyroid stimulating hormone (TSH) 0% 12 $0.00
84295 0% 229 $0.00
82947 0% 198 $0.00
85014 0% 217 $0.00
84520 0% 205 $0.00
82565 0% 223 $0.00
G1012 Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program 0% 185 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 34 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSIDONE, LEIGHANN (PRESIDENT)